Episode 77
Biotech Hangout
00:00
Two Interesting Deals in the Biotech Industry
This chapter focuses on two intriguing deals in the biotech industry. It delves into the recent transaction by Endeavour, led by CEO John Howard, where they in-licensed an ADC, as well as the deal between PTC and Royalty Pharma, where PTC monetized a portion of the obesity world for a billion upfront. The discussion highlights the importance of these deals for future innovation in the biotech sector and touches upon other significant industry developments.
Transcript
Play full episode
